Specialty Billing
Hematology Medical Billing Services
Billing for hematology practices — benign and malignant — where high-cost products, chronic infusion schedules, and monitoring-heavy care define the revenue pattern.
Hematology spans two billing worlds: malignant hematology sharing oncology’s drug-and-infusion intensity, and benign hematology — anemia management, anticoagulation, iron infusions, factor products for bleeding disorders — with its own chronic-care billing rhythm and some of medicine’s most expensive products per dose.
Our hematology billing covers both: infusion suites reconciled like oncology, factor and specialty products billed with the unit precision their prices demand, and the recurring lab-and-visit monitoring engine billed cleanly at volume.
Why Hematology Billing Is Complex
Iron infusions, IVIG, and clotting factor sit high on payer radar: authorization criteria, unit documentation, and site-of-care policies apply at full intensity, and IVIG in particular faces indication-by-indication coverage rules. Chronic infusion schedules mean authorization renewals are a permanent operational layer, and monitoring labs must connect to documented indications to survive frequency edits.
Common Service Categories We Bill
- Therapeutic infusions: iron, IVIG, biologics
- Clotting factor and bleeding disorder management
- Malignant hematology treatment programs
- Anticoagulation management services
- Bone marrow biopsy procedures
Common Denial Causes in Hematology
- Product-specific medical-necessity denials (IVIG, iron, factor)
- Authorization renewal lapses on chronic schedules
- Lab frequency edits on monitoring panels
- Unit-price edits on factor products
Documentation Risks to Watch
- Indication documentation not meeting product-specific coverage policies
- Unit and wastage records incomplete on high-cost products
- Recurring lab orders without refreshed clinical rationale
Coding Considerations
- Factor units bill in product-defined increments at extreme unit prices — reconciliation to dispensing is non-negotiable
- IVIG coverage varies by diagnosis; the billed indication must match policy-listed conditions
Educational note: Coding and payer information on this page is general educational content, not definitive coding, legal, or reimbursement advice. CPT/ICD-10 rules and payer policies change frequently — verify specifics against current official sources and qualified professionals.
Typical Payer Challenges
- Indication-tiered coverage policies per product
- Site-of-care steering for chronic infusions
Hematology Billing FAQs
IVIG denials cite medical necessity even with authorization — how?
Authorization confirms the request met criteria at approval; claims still adjudicate against the policy, and mismatches between billed diagnosis, dose, or interval and the authorized parameters trigger denials. We align claims to the authorization exactly and appeal with policy citations where the payer moved the target.
Can you handle factor product billing for our bleeding disorder patients?
Yes — factor billing is unit-precision work at extreme prices, with assay documentation, per-product increments, and payer-specific requirements. Every factor claim reconciles to dispensing records before submission in our workflow.
Related Specialties and Texas Locations
Information on this website is provided for general educational purposes only and does not constitute legal, medical, coding, reimbursement, payer, or compliance advice. Coding and payer requirements change frequently; verify current rules with official sources and qualified professionals before acting.
Talk to us about hematology billing
Request a free billing assessment and get a clear, no-obligation review of your claims process, denial patterns, and accounts receivable.